Application 209239
- Type
- ANDA
- Sponsor
- GLENMARK PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | SOLIFENACIN SUCCINATE | SOLIFENACIN SUCCINATE | TABLET;ORAL | 5MG | No | No |
| 002 | SOLIFENACIN SUCCINATE | SOLIFENACIN SUCCINATE | TABLET;ORAL | 10MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 68462-386 | solifenacin succinate | solifenacin succinate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-386 | solifenacin succinate | solifenacin succinate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-386 | solifenacin succinate | solifenacin succinate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-386 | solifenacin succinate | solifenacin succinate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-387 | solifenacin succinate | solifenacin succinate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-387 | solifenacin succinate | solifenacin succinate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-387 | solifenacin succinate | solifenacin succinate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-387 | solifenacin succinate | solifenacin succinate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |